However, tumours that displayed a large reduction in Ki-67 index after chemotherapy were more likely to achieve a pathological response: 78% of patients (seven out of nine) with falls of >75% in Ki-67 after treatment were pathological responders compared to 20 out of 75 (27%) of those with less extreme falls in Ki-67. The gene discussed is MKI67; the disease is neoplasm.